RVAC Medicines: Funding, Investors & Team (Sep 2026)
RVAC Medicines is a mRNA platform company engaged in the research and development of innovative products such as vaccines for diseases.
RVAC Medicines has raised $140M across 1 funding round on record, the most recent a Series B of $140M announced in Apr 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
RVAC Medicines Company Profile and Key Stats
Latest funding round on record: Apr 2022.
RVAC Medicines Funding Rounds
RVAC Medicines Founders and Leadership Team
No contact details are on record for this team yet.
RVAC Medicines Funding Compared to Other Biotechnology Startups
RVAC Medicines' latest round of $140M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like RVAC Medicines in Biotechnology and Singapore
Companies Similar to RVAC Medicines
YouLabs is an early-stage, data-driven biotechnology and longevity technology company focused on shifting…
Volition is a worldwide life sciences organization creating straightforward, simple to utilize blood-based…
ImmunoScape is a company focused on immunomics, using a technology platform to analyze and characterize the…
Nuevocor, which has locations in both the United States and Singapore, is working on creating genetic…
Aevice Health Pte Ltd is a Singaporean company that originated from Nanyang Technological University and…
Mirxes is a biotech firm focused on uncovering, advancing, and providing precise preventive healthcare…
BioDefense introduces Bioshield, a product derived from edible ingredients designed to safeguard your food by…
Auristone delivers practical clinical insights through our epigenomics workflows, providing actionable…
ASLAN is a pharmaceutical company that develops novel medicines for global markets. It specializes in…
GDMC is a pharmaceutical organization that specializes in the production and development of genetic…
Meatiply, a company focused on food research, specializes in the creation and manufacturing of meat…
Empowering Healthier Meals by Harnessing the Best from Nature and Combining that our Knowledge of Food…
RVAC Medicines Funding FAQs
What does RVAC Medicines do?
RVAC Medicines is a mRNA platform company engaged in the research and development of innovative products such as vaccines for diseases.
How much funding has RVAC Medicines raised?
RVAC Medicines has raised $140M across 1 round on record. The most recent is a Series B of $140M announced in Apr 2022.
When did RVAC Medicines last raise funding?
RVAC Medicines' most recent funding round on record is a Series B of $140M, announced in Apr 2022.
Who is the CEO of RVAC Medicines?
Xi-Yong Fu is listed as CEO at RVAC Medicines.
Where is RVAC Medicines headquartered?
RVAC Medicines is based in Singapore, Central Region, Singapore.
How many employees does RVAC Medicines have?
RVAC Medicines is in the 101-250 employee band.
How does RVAC Medicines' funding compare to other Biotechnology startups?
RVAC Medicines' latest round of $140M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's RVAC Medicines Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for RVAC Medicines is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.